Difference between revisions of "FHIR Consent Feb 24, 2017"

Revision as of 17:38, 24 February 2017

	Member Name	x	Member Name	x	Member Name	x	Member Name
X	David Pyke CBCC co-Chair	.	Johnathan Coleman CBCC Co-Chair	.	Suzanne Gonzales-Webb CBCC Co-Chair	.	Grahame Grieve FHIR Director
.	Alexander Mense Security Co-Chair	.	Kathleen Connor Security Co-Chair	.	John MoehrkeSecurity Co-Chair	.	Glen Marshall
.	Jim Kretz	.	Tarik Idris	.	Ken Salyards	.	Diana Proud-Madruga
.	M'Lynda Owens	.	David Staggs	.	Ken Sinn (Canada)	.	Beth Pumo
.	Rob Horn	.	William Kinsley	.	Wayne Kubick	.	Serafina Versaggi
.	Igor Sirkovich	.	Adrian Gropper	.	Mike Davis	.	Mohammad Jafari (VA/ESC)
.	Joe Lamy, Aegis	.	Andrew Rampolla (SSA)	.	Joseph Quinn (Optum)	.	none

Roll-call
Planning for additional scope consent work.
- Medical Treatment Consent Directive: Consent to undergo a specific treatment (or record of refusal to consent).
- Research Consent Directive: Consent to participate in research protocol and information sharing required.
- Advance Care Directives: Consent to instructions for potentially needed medical treatment (e.g. DNR).

@@ Line 53: / Line 53: @@
 * Roll-call
 * Planning for additional scope consent work.
+** Medical Treatment Consent Directive: Consent to undergo a specific treatment (or record of refusal to consent).
+** Research Consent Directive: Consent to participate in research protocol and information sharing required.
+** Advance Care Directives: Consent to instructions for potentially needed medical treatment (e.g. DNR).
 ==Minutes==